Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Appl Physiol 70: 778-787, 1991;
8750-7587/91 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Accurso, F. J.
Right arrow Articles by Henson, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Accurso, F. J.
Right arrow Articles by Henson, P.

Journal of Applied Physiology, Vol 70, Issue 2 778-787, Copyright © 1991 by American Physiological Society

ARTICLES

Fetal pulmonary vasodilation after exogenous platelet-activating factor

F. J. Accurso, S. H. Abman, R. B. Wilkening, G. S. Worthen and P. Henson
Department of Pediatrics, University of Colorado School of Medicine, National Jewish Center for Immunology and Respiratory Medicine, Denver.

To determine the fetal pulmonary vascular response to platelet-activating factor (PAF), we studied the hemodynamic effects of the infusion of PAF directly into the left pulmonary artery in 21 chronically catheterized fetal lambs. Left pulmonary arterial blood flow (Q) was measured with electromagnetic flow transducers. Ten-minute infusions of low-dose PAF (10-100 ng/min) produced increases in Q from a baseline of 71 +/- 5 to 207 +/- 20 ml/min (P less than 0.001) without changes in pulmonary arterial pressure. Pulmonary vasodilation with PAF was further confirmed through increases in Q with brief (15-s) infusions and increases in the slope of the pressure-flow relationship as assessed by rapid incremental compressions of the ductus arteriosus during PAF infusion. Infusion of Lyso-PAF had no effect on Q or pulmonary arterial pressure. Treatment with CV-3988, a selective PAF receptor antagonist, but not with meclofenamate, atropine, or diphenhydramine and cimetidine blocked the response to PAF infusion and did not affect baseline tone. Systemic infusion of high-dose PAF (300 ng/min) through the fetal inferior vena cava increased pulmonary arterial pressure (46.5 +/- 1.0 to 54.8 +/- 1.9 mmHg, P less than 0.01) and aorta pressure (44.3 +/- 1.0 to 52.7 +/- 2.2 mmHg, P less than 0.01) while also increasing Q. Neither PAF nor CV-3988 changed the gradient between pulmonary arterial and aorta pressures, suggesting that PAF does not affect ductal tone. We conclude that PAF is a potent fetal pulmonary vasodilator and that the effects are not mediated through cyclooxygenase products or by cholinergic or histaminergic effects.


This article has been cited by other articles:


Home page
 J. Appl. Physiol.Home page
L. C. Clavijo, M. B. Carter, P. J. Matheson, M. A. Wilson, W. B. Wead, and R. N. Garrison
PAF increases vascular permeability without increasing pulmonary arterial pressure in the rat
J Appl Physiol, January 1, 2001; 90(1): 261 - 268.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
B. O. Ibe, F. C. Sander, and J. U. Raj
Platelet-activating factor receptors in lamb lungs are downregulated immediately after birth
Am J Physiol Heart Circ Physiol, April 1, 2000; 278(4): H1168 - H1176.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
B. O. Ibe, S. Hibler, and J. U. Raj
Platelet-activating factor modulates pulmonary vasomotor tone in the perinatal lamb
J Appl Physiol, September 1, 1998; 85(3): 1079 - 1085.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online